| Survival analysis |
| Procedural related death within 30 days |
2/36 (5.6) |
| Post op hospital stay (days) |
8.6±2.1 |
| 30-day all-cause mortality |
2/36 (5.6) |
| 1-year all-cause mortality |
2/36 (5.6) |
| 5-year all-cause mortality |
7/36 (19.4) |
| 10-year all-cause mortality |
20/36 (55.6) |
| Mean all-cause survival (months) |
105.9±8.32 |
| 1-year cardiac event related mortality |
2/36 (5.6) |
| 5-year cardiac event related mortality |
4/36 (11.1) |
| 10-year cardiac event related mortality |
13/36 (36.1) |
| % of cardiac death among all-cause mortality in 10 years |
13/20 (65.0) |
| Cardiac related deaths |
|
| Repeat congestive heart failure & end-stage myocardial failure |
4/13 (30.8) |
| NSTEMI |
8/13 (61.5) |
| Procedure related post CABG |
1/13 (7.7) |
| Non cardiac related |
7/20 (35.0) |
| Gastrointestinal bleeding |
2/7 (28.6) |
| Malignancy |
2/7 (28.6) |
| Infection |
2/7 (28.6) |
| Renal failure |
1/7 (14.3) |
| Cardiac symptoms and LVEF |
|
| Post op NYHA (n=34) |
|
| Class 1 |
11/34 (32.4) |
| Class 2 |
12/34 (35.3) |
| Class 3 |
9/34 (26.5) |
| Class 4 |
2/34 (5.9) |
| Readmission for cardiac events in 10 years |
20/34 (58.8) |
| Post op LVEF (%) (n=30) |
32.2±8.9 |
| LVEF >5% improvement |
16/30 (53.3) |
| Post op LVEF remained <35% |
20/30 (66.7) |
| ICD/CRT-D rates |
6/36 (16.7) |
| Guideline directed medical therapy use |
32/34 (94.1) |
